225 related articles for article (PubMed ID: 16785693)
21. [Case control study of extended-spectrum betalactamase producing Serratia marcescens outbreak in a paediatric intensive care unit].
Adjidé CC; Li-Thiao-Te V; Biendo M; Weibel B; Laurans G; Krim G; Eb F
Pathol Biol (Paris); 2004 Oct; 52(8):423-8. PubMed ID: 15465258
[TBL] [Abstract][Full Text] [Related]
22. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
[TBL] [Abstract][Full Text] [Related]
23. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
[TBL] [Abstract][Full Text] [Related]
24. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
[TBL] [Abstract][Full Text] [Related]
25. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
[TBL] [Abstract][Full Text] [Related]
26. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.
Queenan AM; Shang W; Schreckenberger P; Lolans K; Bush K; Quinn J
Antimicrob Agents Chemother; 2006 Oct; 50(10):3485-7. PubMed ID: 17005839
[TBL] [Abstract][Full Text] [Related]
27. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
[TBL] [Abstract][Full Text] [Related]
28. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
[TBL] [Abstract][Full Text] [Related]
30. Repeated epidemics caused by extended-spectrum beta-lactamase-producing Serratia marcescens strains.
Luzzaro F; Perilli M; Migliavacca R; Lombardi G; Micheletti P; Agodi A; Stefani S; Amicosante G; Pagani L
Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):629-36. PubMed ID: 9832264
[TBL] [Abstract][Full Text] [Related]
31. KPC-PRODUCING Serratia marcescens IN A HOME-CARE PATIENT FROM RECIFE, BRAZIL.
Margate E; Magalhães V; Fehlberg LC; Gales AC; Lopes AC
Rev Inst Med Trop Sao Paulo; 2015; 57(4):359-60. PubMed ID: 26422164
[TBL] [Abstract][Full Text] [Related]
32. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
[TBL] [Abstract][Full Text] [Related]
33. Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates.
Yu WL; Lin CW; Wang DY
J Microbiol Immunol Infect; 1998 Sep; 31(3):171-9. PubMed ID: 10496154
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients.
Troillet N; Carmeli Y; Venkataraman L; DeGirolami P; Samore MH
J Hosp Infect; 1999 May; 42(1):37-43. PubMed ID: 10363209
[TBL] [Abstract][Full Text] [Related]
35. Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases.
Jeong SH; Song W; Park MJ; Kim JS; Kim HS; Bae IK; Lee KM
Int J Antimicrob Agents; 2008 May; 31(5):467-71. PubMed ID: 18337065
[TBL] [Abstract][Full Text] [Related]
36. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
37. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of an SME-2-producing Serratia marcescens isolate in Canada.
Carrër A; Poirel L; Pitout JD; Church D; Nordmann P
Int J Antimicrob Agents; 2008 Feb; 31(2):181-2. PubMed ID: 18083009
[No Abstract] [Full Text] [Related]
39. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
40. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
